News & Releases
Video: Breakthroughs in GI Cancer Detection: The Role of AI and Data (Target Cancer)
Join us as we explore gastrointestinal (GI) knowledge with renowned expert Dr. Michael Byrne. With extensive medical and AI expertise, Michael provides a unique perspective on early cancer diagnosis and the challenges in detecting GI cancers. From colon to stomach and esophageal cancer, discover advancements in screening techniques and the role of AI in improving outcomes. Uncover the potential of AI solutions in revolutionizing GI healthcare and catching cancer early.
DDW 2023: WEO Plenary Meeting: Novel applications of CADx
Satisfai Health VP medical affairs Dr. Nasim Parsa presented the novel applications of CADx to arbitrate between discordant endoscopic & pathologic diagnosis
DDW 2023: AI Models for Barrett’s & Early Esophageal Cancer
Satisfai Health Scientific Advisor & Director of Upper GI Cancers Dr. Helmut Messmann and Advisor Jason Samarasena MD presented AI in BE Neoplasia Detection: The New Normal or Panacea at a Breakfast Connections session on May 7, 2023 at DDW 2023.
DDW 2023: Esophageal Cancer Action Network “The Future of Innovation in Esophageal Diseases”
Esophageal Cancer Action Network Event at DDW
Satisfai Health Adds Chief Strategy Officer and VP of Business Development
Satisfai Health Adds Chief Strategy Officer and VP of Business Development to Accelerate Gastroenterology and GI Endoscopy AI Solutions
Satisfai Leads Panel at 2023 AGA Tech Summit
Dr. Michael Byrne, CEO, Satisfai Health, was pleased to be a moderator in a session on AI in Endoscopy along with other global names in AI.
Satisfai Health Purchases Assets of Docbot, Inc.
Solidifies Satisfai as one of the leading technology companies globally in artificial intelligence for gastroenterology
Alimentiv, Satisfai Health, and Virgo Announce Partnership to use AI driven technology to Enhance Clinical Trials in IBD and other GI Diseases
The partnership enables advanced AI-fueled HD video capture, decision support, and clinical research tools for Alimentiv’s global clinical trial investigator site network.
Mayo Clinic Women in Gastroenterology & Hepatology Showcase: If you cannot see it, you cannot be it!
A digital symposium delivered entirely by women of national and international recognition in the fields of gastroenterology and hepatology.
Satisfai Health Announces Collaboration with the International Bowel Ultrasound (IBUS) Group
The application of artificial intelligence technology to intestinal ultrasound procedures will accelerate quality and standardization, driving adoption of this highly cost-effective modality.
Satisfai Health Appoints Fort Capital as Financial Advisor & Announces the Appointment of VP, Regulatory Affairs and Quality Assurance
Satisfai Health accelerates corporate growth with key additions to the team.
Satisfai Health acquires global license for AI software to detect early cancer in Barrett's Esophagus
Early detection of esophageal cancer with the help of artificial intelligence: research results of the
team led by Prof. Dr. Christoph Palm are now used in clinical practice around the world.
Satisfai Health and AIG Hospitals announce collaboration to transform Gastroenterology and Gastrointestinal (GI) Endoscopy with Artificial Intelligence
Partnership gives both groups the exciting opportunity to accelerate development of Satisfai’s innovative suite of AI solutions across the spectrum of Gastroenterology and GI Endoscopy, and to establish Satisfai Health and AIG Hospitals as global leaders in this space.